LM-609
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Angiogenesis inhibition, which has been extensively studied for the treatment of various malignancies, is beginning to emerge as…
Vitaxin is a humanized version of LM-609 (an mAb licensed from the Scripps Research Institute and Dr David Cheresh in May 1994…
This study asks which occurs first in time for remote responses: a dilation or a remote change in flow. Arteriolar diameter…
Osteopontin (OPN) promotes attachment and spreading of cells in an RGD dependent fashion, suggesting that OPN interacts with…